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The fate of an endothelium layer after preconditioning
Saami K. Yazdani, PhD,a,c Bryan W. Tillman, MD, PhD,a,b Joel L. Berry, PhD,c Shay Soker, PhD,a and
Randolph L. Geary, MD,a,b Winson-Salem, NC
Background: A strategy in minimizing thrombotic events of vascular constructs is to seed the luminal surface with
autologous endothelial cells (ECs). The task of seeding ECs can be achieved via bioreactors, which induce mechanical
forces (shear stress, strain, pressure) onto the ECs. Although bioreactors can achieve a confluent layer of ECs in vitro,
their acute response to blood remains unclear. Moreover, the necessary mechanical conditions that will increase EC
adhesion and function remain unclear. We hypothesize that preconditioning seeded endothelium under physiological
flow will enhance their retention and function.
Objective: To determine the role of varying preconditioning protocols on seeded ECs in vitro and in vivo.
Methods: Scaffolds derived from decelluarized arteries seeded with autologous ECs were preconditioned for 9 days. Three
specific protocols, low steady shear stress (SS), high SS, and cyclic SS were investigated. After preconditioning, the seeded
grafts were exposed to 15 minutes of blood via an ex vivo arteriovenous shunt model or alternately an in vivo
arteriovenous bypass graft model.
Results: The shunt model demonstrated ECs remained intact for all conditions. In the arteriovenous bypass model, only
the cyclic preconditioned grafts remained intact, maintained morphology, and resisted the attachment of circulating
blood elements such as platelets, red blood cells, and leukocytes.Western blotting analysis demonstrated an increase in the
protein expression of eNOS and prostaglandin I synthase for the cyclic high shear stress-conditioned cells relative to cells
conditioned with high shear stress alone.
Conclusion: Cyclic preconditioning has been shown here to increase the ECs ability to resist blood flow-induced shear
stress and the attachment of circulating blood elements, key attributes in minimizing thrombotic events. These studies
may ultimately establish protocols for the formation of a more durable endothelial monolayer that may be useful in the
context of small vessel arterial reconstruction. (J Vasc Surg 2010;51:174-83.)
Clinical Relevance: The importance of ECs toward patency has been demonstrated by the superior performance of
endothelialized vein compared with prosthetic vascular graft materials. This article evaluates conditioning protocols for
bioengineered vascular conduits to improve endothelial retention. This study describes approaches to improve bioengi-
neered vessels as a potential alternative to conventional prosthetic vascular grafts.Vascular graft failure due to thrombosis and intimal
hyperplasia is an unsolved problem.1 Failure of synthetic
grafts has been associated with a lack of functionality of
vascular cells, mismatch of mechanical properties between
host vessel and graft, and poor host remodeling.2-4 Bio-
engineered vessels have shown promise in overcoming
these issues, as evidenced by their long-term patency and
functional arterial segments in preclinical models.5,6 In
native arteries, endothelial cells (ECs) provide a continu-
ous, selectively permeable, thromboresistant barrier be-
tween circulating blood and the arterial wall. Moreover,
they play important roles in vessel tone, platelet and leuko-
cyte adhesion, and smooth muscle migration and prolifer-
ation.7 A common strategy for minimizing thrombogenic-
ity of bioengineered vessels is the seeding of autologous
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174vascular ECs on the luminal surface of the graft material
that will be implanted back into the animal receiving the
graft.8 ECs can be derived from several sources including
artery, vein, bone marrow, and blood. Endothelial progen-
itor cells that circulate in the blood stream and are derived
from the bone marrow represent a new potential source of
ECs that would be ideal for cardiovascular therapies.9 ECs
derived from endothelial progenitor cells have shown
promising results in the development of blood vessel sub-
stitutes.5
The approach to seeding grafts with ECs has tradition-
ally been performed by either static seeding (solution of
cells on graft surface) or static seeding followed by flow
preconditioning.10 Static seeding alone has not shown
promising results in either vitro or in vivo studies.11-13
These disappointing results have been attributed to the lack
of a confluent EC monolayer and low EC retention rates in
vivo. Improved EC adherence has been achieved by a
variety of methods that include optimizing surface coat-
ings, manipulation of the extracellular matrix composition
and geometry, improvements in static seeding techniques,
and exposing ECs to physiologic mechanical forces.10,14-16
Among these, exposing ECs to fluid shear stress and cyclic
mechanical strain was determined to be one of the most
important features in developing a confluent endothelium
monolayer with high cell retention rates.
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preconditioning protocols in exposing cells to shear stress,
pressure, and strain forces.13,17 Many investigators have
been able to show the benefits of bioreactor precondition-
ing in improving seeding, retention, and function of ECs
on a variety of scaffolds in vitro.18,19Missing in themajority
of these studies is the acute behavior of preconditioned ECs
to blood flow. Specifically, the influence of mechanical
forces on the ability of cells to resist shear stress, maintain
morphology, and interact with circulating blood elements
have not been described. These studies are important to
establish the appropriate conditions of EC seeding and
preconditioning to minimize acute thrombogenic activities
and prolong patency of vascular grafts.
The current work investigated the attachment, conflu-
ency, and retention of ECs derived from circulating endo-
thelial progenitor cells on a decellularized scaffold using
specific preconditioning protocols in both in vitro and in
vivo environments. We hypothesized that simulation of
physiologic arterial mechanical conditions would improve
the adherence and function of ECs lined on a vascular
scaffold to create a more durable monolayer of bioengi-
neered vessel.
METHODS
Cell isolation and culture. Endothelial progenitor
cells (EPCs) were isolated and cultured as previously de-
scribed using a proprietary endothelial recovery column
system.20 An extracorporeal EPC purification column was
cycled for 1800 mL of blood on adult (aged 4-12 months)
female sheep after exposure of the carotid artery and jugular
vein Subsequently, cells were eluted from the matrix with
trypsin and cultured in EGM-2 endothelial growth media
(Cambrex, East Rutherford,NJ) on fibronectin-coated plates.
Media was changed at 5 and 8 days after which numerous
endothelial colonies emerged and were expanded as mature
ECs.
Scaffold preparation. Decellularized porcine arterial
segments were prepared as described elsewhere.5 Briefly,
carotid arterial segments were obtained from large pigs
from a local abattoir. The blood vessels had an internal
diameter of 4 mm to 5 mm and were cut into segments of
approximately 50 mm in length. Vessels were washed in
deionized (DI) water for 48 hours and incubated in 0.05%
trypsin-ethylenediaminetetraacetic acid (EDTA; GIBCO,
Invitrogen, Carlsbad, Calif) for 1 hour. The vessels were
incubated in decellularization solution (490 mL deionized
[DI] water, 10 mL Triton-100X, 3.4 mL ammonium hy-
droxide) for 3 days in a mechanical rotating shaker at 4°C.
The decellularization solution was changed daily. The de-
cellularized vessels were then placed in DI water for an
additional 48 hours to wash away any residual processing
chemicals from the matrix and then frozen for 24 hours in
a 80°C freezer, lyophilized (LABCONCO, Kansas City,
Mo), and sterilized with ethylene oxide.
Bioreactor design. We developed a bioreactor system
that permitted (1) seeding of acellular substrates, (2) gen-
eration and recording of physiologic flow and pressure, (3)maintenance of gases and nutrients in the culture medium,
and (4) maintenance of temperature and sterility (Fig 1).
The pressure was monitored via a catheter pressure trans-
ducer (Millar Instruments, Houston, Tex) and was con-
trolled by adjusting the distal resistance. The flow was
controlled by varying the output of a gear pump (Ismatec,
Glattbrugg, Switzerland). The output variation of the flow
rate was controlled by a computer running LabVIEW (Na-
tional Instruments, Austin, Tex), which generated steady,
sinusoidal, and/or any user-defined waveform with user
control over the frequency and time duration for any num-
ber of steps. This feature permitted the bioreactor system to
steadily increase prescribed flow rates automatically over
any duration. The flow was monitored via an ultrasonic
flow meter (Transonic Systems, Ithaca, NY) that was posi-
tioned upstream of the bioreactor.
Static seeding and preconditioning protocols.
EPC-derived ECs were collected from culture dishes and
resuspended inmedia at a density of 1.0 106 cells/mL. In
a sterile culture hood, the ethylene oxide sterilized biore-
actor parts were assembled. The cells were collected and
placed into the lumen of the vessel via three-way valves. The
bioreactor was then placed on a custom-built device, which
rotated the bioreactor at 0.34 rpm (approximately 3 min-
utes/cycle) for 2 hours to complete the static seeding
procedure.
Following static seeding, the bioreactor was connected
to the flow system. Table I illustrates the preconditioning
methods for each flow type. The Low SS protocol exposed
the cells to a mean wall shear stress value of 1.7 dynes/cm2
Fig 1. Pulsatile bioreactor system. (A) Illustration of the bioreac-
tor system consisting of a computer-controlled gear pump, flow
reservoir, ultrasonic flowmeter, and a pressure catheter. (B) Illus-
tration of the bioreactor housing unit equipped with a bypass
tubing system.for a duration of 9 days. The High SS protocol exposed the
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peak value of 13.2 dynes/cm2 after 9 days. The cyclic
protocol induced similar values of shear stress; however,
mechanical strain was superimposed to the endothelium
layer starting from day 5. Therefore, the ECs were sub-
jected to cyclic shear stress, oscillating pressure, and me-
chanical strain at a rate of 60 beats per minute. The wall
shear rate values induced by the bioreactor system were
based on the volumetric flow rates and the viscosity of our
fluid. The mean shear stress was calculated by the Hagen-
Poiseuille equation:
mean (4Q) ⁄ (R3)
in which Q was the mean volume flow rate,  was the
dynamic viscosity, and R was the lumen radius. The as-
sumption was made that the flow through our construct
vessels was laminar. The viscosity was measured with a
temperature-controlled rotational viscometer (Brookfield,
Stroughton, Mass). These tools provided a very accurate
measurement of the viscosity ( 1% of range) and flow rate
( 1 mL/min).
Ex vivo arteriovenous shunt. To expose the precon-
ditioned endothelium to circulating blood, an ex vivo
arteriovenous shunt model was developed. Female Dorper
Cross sheep between the ages of 4 and 12 months were
purchased from a local farm (Mocksville, NC). Sheep were
anesthetized and their right (or left) carotid artery and
jugular vein exposed through a neck incision. Heparin (100
units/kg) was then administered to the animals prior to the
cannulation of the bioreactor tubing to the carotid artery
and jugular vein. The bioreactor was positioned via leur
fittings between the tubing and primed with saline to
ensure no air would be introduced into the vascular system.
Three grafts (mean length  40 mm, mean internal diam-
eter  5 mm) for each preconditioning protocol were
subjected to 15 minutes of blood flow and then rinsed with
60 mL of phosphate buffered saline (PBS). The grafts were
then pressure fixed with 2.5% Glutaraldehyde for 48 hours
and midgraft sections were prepared for scanning electron
microscopy.
Arteriovenous bypass graft model. In order to assess
Table. Detailed bioreactor protocols of the preconditionin
Shear stress (dynes/cm2)
Day Low SS Steady SS
Cyclic SS
Diastole Sy
1 1.7 1.7 1.7
2 1.7 1.7 1.7
3 1.7 3.3 3.3
4 1.7 3.3 3.3
5 1.7 5 3.3
6 1.7 8.3 6.6
7 1.7 9.9 6.6
8 1.7 11.6 8.3 1
9 1.7 13.2 9.9 1
SS, Shear stress.the preconditioned grafts to blood flow in a more physio-logic setting, an in vivo arteriovenous bypass graft model
was developed. As in the shunt model, sheep were given
oral antiplatelet therapy 24 hours prior to any surgical
procedure. Sheep were anesthetized and their right (or left)
carotid artery and jugular vein exposed through a neck
incision. Heparin (100 units/kg) was then administered to
the animals prior to the implantation of the seeded bioengi-
neered vessels. The bioengineered vessel was removed from
the bioreactor, and a portion of each graft was taken for
preimplantation analysis. The grafts (mean length  50
mm, mean internal diameter  5 mm) were sewn onto the
vein and onto the artery with 6-0 polypropylene suture
(Surgipro; Syneture, Norwalk, Conn) in an end-to-side
fashion with a standard surgical technique. The direction of
blood flow, from artery to vein, corresponded to the direc-
tion of the medium within the bioreactor system. After 15
minutes, the bioengineered vessel was removed and rinsed
with 60 mL of PBS, and midgraft sections were processed
for scanning electron microscopy (SEM) analysis. All the
animal care complied with the “principles of Laboratory
Animal Care” and received approval from the Wake Forest
University Health and Sciences Animal and Care Use com-
mittee.
Scanning electron microscopy. To analyze EC mor-
phology and assess the luminal surface of the precondi-
tioned grafts after blood flow, SEM was utilized. Briefly,
samples (rings) were fixed in 2.5% Glutaraldehyde solution
(Sigma, St. Louis, Mo; 1:10 dilution in PBS) for 48 hours
and then cut open and pinned to small strips of Teflon,
exposing the luminal surface and dried using a critical-point
drying apparatus. Samples were then gold coated and ana-
lyzed for endothelial retention, morphology, and surface
characterization (SEM Model S-2260N; Hitachi Co, To-
kyo, Japan). For each preconditioning method, three grafts
were analyzed for SEM. Attached blood elements that in-
cluded platelets, white blood cells, and red blood cells were
counted for each preconditioned methods (n  9 for each
preconditioning group) at a high magnification (1000 X).
Histology and immunohistochemistry analysis. For
each set of experiments (bioreactor, ex vivo shunt, fistula) the
bioengineered vessels were rinsed with PBS and pressure-
ethods
Pressure (mm Hg)
Low SS Steady SS
Cyclic SS
Diastole Systole
19 19 19 19
19 19 19 19
19 25 25 25
19 25 25 25
19 35 25 35
19 60 46 60
19 74 46 74
19 92 60 92
19 115 74 115g m
stole
1.7
1.7
3.3
3.3
5
8.3
9.9
1.6
3.2perfused fixed in 10% formalin and paraffin embedded. The
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progenitor cells. Native porcine carotid arteries (A) were decellularized in a detergent solution for 72 hours. BothH&E
(B) and scanning electron microscopy (C) confirmed the removal of native vascular cells within the matrix. Autologous
endothelial progenitor cells were successfully differentiated in vitro (D) and expressed endothelial-specific markers of
(E) eNOS and (F) vWF. H&E, Hematoxylin and eosin.Fig 3. Histological and SEM images of static and low shear stress preconditioned grafts. Grafts statically seeded with
autologous EPC did not produce a confluent monolayer as observed with (A) DAPI and (B) SEM images. Grafts
seeded for a duration of 9 days under low shear stress conditions displayed a confluent monolayer in both (C) H&E and
(D) SEM images. DAPI, 4=-6-diamidino-2-phenylindole; EPC, endothelial progenitor cells; H&E, hematoxylin and
eosin; SEM, scanning electron microscopy.
opy.
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(Sakura Finetek; Torrance, Calif) and frozen in liquid ni-
trogen. Cryostat sections (5 Lm) were analyzed by 4=-6-
diamidino-2-phenylindole (DAPI; Vector, Burlingame,
Calif). For immunohistochemical analysis, EPCs seeded onto
eight-chamber slides were fixed with 2% paraformaldehyde,
washed, and incubated with primary antibodies of vWF
(DAKO,Carpinteria, Calif) and eNOS (#610297, BDTrans-
duction Lab, San Jose, Calif) using 1:25 and 1:50 dilutions.
For staining of Lectin, cells were incubated with biotinyl-
ated UEA Lectin (Vector). Primary antibodies or lectin
were then localized with FITC anti-rabbit, FITC anti-
mouse, or FITC avidin (Vector) at 1:100 dilution.
Western-blot analysis. To determine changes in ex-
pression of functional markers due to the mechanical forces
induced by the bioreactor preconditioning on the seeded
endothelium, quantitative Western blotting analysis was
performed. To prepare the cell lysates, grafts were removed
from the bioreactor, sliced and pinned open onto Teflon
sheets, and rinsed with PBS. Three hundred microL of the
lysis buffer [50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM
EDTA, 0.5%NP-40] were pipette onto the luminal surface,
followed by manual scrapping of the EC. The cell/buffer
solutions were agitated for 30 minutes at 4° C and centri-
fuged at 13,000 rpm for 10 minutes. The supernatant (cell
lysates) was then collected and separated by sodium dode-
Fig 4. Histological and SEM images of high shear stress
of 9 days under high shear stress condition displayed a co
(A) H&E and (B) SEM images. Similar results were obse
protocol as observed in both the (C) H&E, and (D) S
Hematoxylin and eosin; SEM, scanning electron microsccyl (lauryl) sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Immobilon-P membrane. Anti-
eNOS (BD) and anti-Prostaglandin I synthase (Abcam,
Cambridge, Mass) were used to detect endothelial specific
proteins. Gel-Pro Analyzer software (Media Cybernetics,
Silver Spring, Md) was utilized to perform densitometry
measurements on six samples preconditioned under High
SS (n  3) and Cyclic SS (n  3) protocols.
Statistical analysis. All results are presented as mean
standard deviation. Comparisons among the groups were
made using a Student’s t test with JMP software (Carey,
NC). The results were considered significant if the P value
was less than .05.
RESULTS
Decellularization process. In order to obtain a scaf-
fold composed of a biologic framework that would support
endothelial cell growth, we decellularized segments of por-
cine common carotid arteries. These segments possessed an
internal luminal diameter of 4 mm to 5 mm and were
approximately 50 mm in length. Arterial segments sub-
jected to decellularization and lyophilization maintained
their tubular appearance. Hematoxylin and eosin (H&E)
staining and scanning electron microscopy (SEM) im-
ages of the decellularized vessels showed multiple layers
of collagenous fibers within the vessel walls (Fig 2).
yclic preconditioned grafts. Grafts seeded for a duration
nt monolayer with endothelium alignment as seen with
ith cells preconditioned with the cyclic preconditioning
mages. Direction of f low is indicated by arrow. H&E,and c
nflue
rved w
EM iThese results demonstrate that the decellularization pro-
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porous matrix.
Static seeding of EPC-derived EC. Although the
decellularized arterial segments maintained an intact tubu-
lar structure, a functional confluent EC layer is an essential
component for the prevention of graft thrombosis and
occlusion. We have previously used sheep endothelial cells
derived from EPC to coat decellularized vessels to prevent
thrombosis.5 The EPC successfully differentiated and ex-
panded in culture to form a typical EC monolayer at
confluence (Fig 2). Immunohistochemical analysis of EPC-
derived EC stained positive for with anti-von-Willebrand
factor (vWF), VEGFR2, UEA-lectin, and eNOS. These
results indicate that we were able to obtain homogeneous
cultures of EPC-derived EC that possess EC phenotype
Fig 5. Luminal surface of preconditioned grafts after th
nonseeded, (B) static-seeded, (C) low shear stress, (D) hi
a lack of adherence of blood elements to the endothelium
Pressure and flowmeasurements of the ex vivo shunt mod
electron microscopy.and express specific EC markers.Fig 3A and 3B show representative examples of results
obtained after static seeding. The data demonstrated that
the EC adhered to the luminal surface, but it could not
develop a confluent monolayer. The seeding efficiency was
calculated to be approximately 78%. This calculation was
achieved by collecting and counting the unattached cells
from luminal volume and comparing it to the original cell
count. Doubling the static seeding time to 4 hours dis-
played similar results and did not significantly alter the
seeding efficiency (76%).
Bioreactor preconditioning. Following the static
seeding of the endothelium, we exposed the cells to the
three preconditioning protocols for a total duration of 9
days (see Table I). TheH&E results demonstrated a mono-
layer of cells on the luminal surface for all three protocols
ivo shunt model. SEM images of the surface for the (A)
ear stress, and (E) cyclic preconditioned grafts illustrated
ditioned under shear stress values  10 dynes/cm2. (F)
irection of flow is indicated by the arrow. SEM, Scanninge ex v
gh sh
con
el. D(Fig 3C – Low SS, Fig 4A – High SS, Fig 4C- cyclic). The
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for all protocols (Fig 3D, 4B, 4D). However, the cell
morphology and orientation differed within the groups.
The Low SS preconditioned EC demonstrated a cobble-
stone-like morphology with no cellular orientation (Fig
3D). The High SS and cyclic preconditioned EC demon-
strated an elongated morphology with cellular orientation
parallel to the direction of flow (Fig 4B, 4D).
Ex vivo arteriovenous shunt. To determine the in-
teraction of the preconditioned endothelium with circulat-
ing blood, an ex vivo shunt model was implemented. The
ex vivo shunt model has been used in the past as a tool to
assess cell retention and platelet deposition.21,22 For our
studies, the preconditioned endothelium layer was exposed
to blood flow for 15 minutes. This exposure time was
determined from our own experience in working with these
scaffolds in a sheep model and from previous publications
demonstrating that in a sheep shunt model, blood element
depositions were observed starting only after 5 minutes.21
Blood flow circulated for a duration of 15 minutes through
the grafts with an average flow rate of 65 mL/min and
pressure range of 55 mm Hg to 70 mm Hg (Fig 5F).
Representative SEM images for each preconditioning
method are shown in Fig 5. The data demonstrated that the
endothelium layer remained equally intact for the Low SS,
High SS, and cyclic preconditioning protocols during the
ex vivo shunt, albeit with more pronounced cell alignment
in the latter two conditions. Moreover, the High SS and
cyclic preconditioning protocols were more resistant to
circulating blood elements. Fig 6 summarizes the attach-
ment of blood elements (platelets, leukocytes, red blood
cells) to the luminal surface for each preconditioning pro-
tocol.
In vivo arteriovenous bypass graft model. Although
the ex vivo shunt provided a simple method to expose the
Fig 6. Quantification of blood elements of the luminal surface of
preconditioned grafts. Preconditioned grafts were exposed to 15
minutes of blood flow via the ex vivio shunt model. Significant
differences (*) were observed between the cyclic and high shear
stress group versus the nonseeded, static, and low shear stress
groups in regard to platelet attachment. White blood cells (WBC)
were significantly higher (*) in the static-seeded group as com-
pared with the other four preconditioned groups. Red blood cells
(RBC) were mostly observed in the nonseeded and static precon-
ditioned groups.preconditioned endothelium to circulating blood, the re-sults suggested that this model did not accurately mimic the
mechanical environment of an implanted vascular graft. In
fact, our calculations suggest a subphysiologic shear of only
4.5 dynes/cm2. Energy losses from serial connectors and
tubing are likely responsible for the diminished shear stress
component. To overcome these limitations and to evaluate
the in vivo retention of endothelial cells in a more physio-
logic setting, preconditioned grafts were sutured between
the carotid artery and the jugular vein, creating an arterio-
venous bypass graft model. The average flow rates in this
model have been measured by our group via duplex ultra-
sonography to be in the range of 750mL/min, a significant
increase as compared with the ex vivo shunt model. More-
over, the calculated shear stress of 54 dynes/cm2 is more
consistent with physiologic conditions of arteriovenous
bypass grafts. Grafts preconditioned under theHigh SS and
cyclic protocols were tested as well as nonseeded and static-
seeded. Representative images for each group are presented
in Fig 7. The data demonstrated that the endothelium
monolayer remained intact and maintained its morphology
only for the cyclic preconditioning protocols. No cells
could be observed for the static seeding protocol. TheHigh
SS preconditioned ECs, could only be observed in patches,
with loss of cell orientation. The antithrombogenic prop-
erties of the cells could be clearly observed in the cyclic
preconditioning protocol.
Expression of functional markers of endothelial
function in High SS vs Cyclic SS conditioned grafts.
To further understand the effects of bioreactor condition-
ing of the seeded endothelium, immunoblotting analyses
were performed on cells from grafts exposed to theHigh SS
and Cyclic protocols to determine any changes in the
expression of eNOS and prostaglandin I synthase (PGIS) on
these cells that appear morphologically identical off the biore-
actor. eNOS and PGIS trigger the release of nitric oxide and
prostaglandin, respectively, which play important roles in the
inhibition of platelets and leukocytes to the vascular endothe-
lium. Expression of these proteins has been shown to be
stimulated bymechanical forces.23,24 The data demonstrated
a significant increase in expression of eNOS (High SS;
49.65  8.39 OD vs Cyclic SS; 87.64  11.91 OD, P 
.02] and PGIS [High SS; 8.36  2.87 OD vs Cyclic SS;
90.73  12.36 OD, P  .001]) for the cyclic precondi-
tioned cells (Fig 7F).
DISCUSSION
Large, high-flow conduits such as Dacron and PTFE
have been used for over 50 years with impressive long-
term patency exceeding 86%.25 Several reports have
highlighted the poor endothelial lining of prosthetic
grafts even after extended periods of implantation,26,27
suggesting that in the context of high flow, large-vessel
reconstruction, endothelium may be less important for
patency. In contrast, the role of endothelium in small-
diameter grafts appears to be more substantial, evi-
denced by the superiority of autologous vein over pros-
thetic grafts.28,29 Endothelial cells play a pivotal role in
the prevention of platelet adherence, this in turn directly
al pro
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platelet degranulation,30 with release of PDGF and
TBF-, for instance, that are believed to be important in
late graft failure by intimal hyperplasia (IH).31,32 De-
spite these potential advantages, efforts to seed endothe-
lial cells onto prosthetic grafts have been difficult, in part
due to electrostatic properties of PTFE that resists ad-
herence of endothelial cells.
The current paradigm, particularly in tissue engineer-
ing, is to seed and coat the luminal surface of the graft using
autologous endothelial cells.8 Circulating EPC served as
the source for the autologous ECs in this study due to their
Fig 7. Luminal surface of preconditioned grafts after t
grafts were exposed to 15 minutes of blood flow in an ar
endothelial coverage in the (B) static-seeded and (C) hig
the surface of the (A) nonseeded, (B) static-seeded, and (
the cyclic shear stress-conditioned grafts displayed a high
circulating blood element. (E) A representative duplex
bypass model. (F) Western blot analyses of high shear st
Direction of flow is indicated by arrow. EPC, Endothelihigh expansion capabilities and minimally invasive methodof procurement.5,20 Vascular bioreactors, which can reca-
pitulate a variety of physiologic mechanical conditions to
seeded ECs, have been designed as a tool for developing a
confluent monolayer. In fact, many researchers have been
successful in developing an endothelium layer in vitro on a
variety of scaffolds;5,6,19 however, only a limited number of
studies exist on the acute response of the preconditioned
ECs to circulating blood in vivo. The important role of flow
and shear stress in endothelial cell adaptation has been
described in several reports;33,34 however, the role of cyclic
mechanical forces on EC morphology and retention has
not been well investigated. To this end, we have developed
vivo arteriovenous bypass graft model. Preconditioned
venous bypass model. The SEM results displayed loss of
ar stress groups. Circulating blood elements adhered to
e high shear stress preconditioned groups; however, (D)
tion rate of endothelial cells with minimal attachment of
orm of the midgraft portion of the arteriovenous graft
nd cyclic preconditioned EPC-derived endothelial cells.
genitor cells; SEM, scanning electron microscopy.he in
terio
h she
C) th
reten
wavef
ress aa bioreactor system that induced three specific mechanical
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vitro and in vivo. Despite an endothelial monolayer in all of
the dynamic preconditioning protocols, cell orientation
with respect to the direction of flow was only observed in
bioengineered vessels experiencing physiologic levels of
shear stress, including High SS and Cyclic SS.
Next, we tested our preconditioned grafts in an arte-
riovenous ex vivo shunt model and an in vivo arteriovenous
bypass graft model. The data from the ex vivo arteriovenous
shunt experiments demonstrated endothelial adherence for
all three dynamic preconditioning protocols with the high-
est degree of cellular alignment observed in the HSS and
Cyclic SS conditioned grafts. The high retention rates of
the endothelium were expected, given that the flow
through the shunt was measured at approximately 60 mL/
min, which corresponds to a relatively subphysiologic mean
wall shear stress value of approximately 4.5 dynes/cm2.
However, even with these mechanical conditions, the anti-
thrombotic properties of the varying preconditioning pro-
tocols were apparent. The endothelium that was conditioned
under High SS and Cyclic SS conditions demonstrated a
statistically significant reduction in the attachment of blood
elements, particularly platelets, as compared with other con-
ditions.
In order to evaluate a more physiologic degree of shear
stress, an in vivo arteriovenous bypass graft model was
examined. The average flow rates through these grafts were
approximately 750 mL/min, resulting in a mean wall shear
stress value of 54 dynes/cm2. Under these more stringent
conditions, a difference between grafts conditioned under
High SS and Cyclic SS became evident, with Cylic SS
conditioned grafts showing substantially improved endo-
thelial retention and resistance to circulating blood ele-
ments. Immunoblotting results similarly reveal an enhance-
ment expression of selected functional markers eNOS and
prostaglandin I synthase (PGIS) in cyclic conditioned grafts
compared with grafts conditioned with High SS alone.
These latter findings represent only a small fraction of the
cytokines and adhesion molecules involved in a functional
endothelium36-38 but nevertheless suggest the importance of
future investigation into the role of both cyclic shear stress and
cyclic circumferential strain on endothelial function.
Several groups have described that in addition to shear
stress, that cyclic circumferential strain may provide yet
another dimension of endothelial adaptation.35,36 This
strain may be encountered during the rhythmic changes in
scaffold diameter that mediate a circumferential stretch and
may also modulate endothelial cells independently of the
effects of shear stress. These features may explain the differ-
ences observed in this study between grafts conditioned with
High SS alone versus those conditioned with Cyclic SS.
In summary, ECs have been shown to respond to
mechanical forces by changes in morphology and function
in vitro. In the present study, we investigated the acute
response of preconditioned ECs in vivo for a variety of
bioreactor mechanical conditions. This study suggests the
importance of including cyclic mechanical forces above and
beyond High SS alone during the preconditioning phase interms of endothelial retention and ability to resist circulat-
ing blood elements, such as platelets, under physiologic
conditions. In a clinical setting, it is possible that these
features may aid in long-term patency of grafts used in
vascular reconstruction. Continued optimization of cyclic
shear preconditioning may ultimately allow use of bioengi-
neered vessels as an endothelialized alternative to tradi-
tional prosthetic graft material in vascular reconstruction.
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A major obstacle limiting the success of vascular conduit
placement remains the limited ability to obtain endothelial cover-
age of the graft luminal surface. Among the beneficial functions of
a confluent endothelium are thromboresistance, selective perme-
ability, and interactions with circulating blood elements and un-
derlying smooth muscle.
Clinical and laboratory results show that large-diameter high-
flow systems tolerate the use of conduits that lack an endothelial
lining. That is not the case for small caliber systems and systems
that have slower flow.
Conduits with slow blood flow and smaller-caliber conduits
perform poorly due to thrombotic complications, possibly due to
the lack of nitric oxide and prostacyclin and the longer interaction
of the blood elements with the nonendothelialized luminal surface.
This study and others like it focus on defining methods for
creating a conduit that has a confluent luminal endothelial lining
that tolerates placement in the circulation.
The scaffold, matrix or material of the graft, and the source
and conditions under which the endothelial cells are harvested and
placed on the conduit are important in determining the degree of
success in achieving endothelial confluence and the durability of
the endothelial layer when challenged with flow conditions. The
authors have demonstrated clearly that, in the short term, themore
complex culture conditions of cyclic shear stress produce an endo-
thelial graft lining that functions in a manner superior to that
produced by conditions of steady shear stress at low or high levels.noted in terms of maintenance of integrity of the endothelial layer
and inhibition of adhesion of circulating blood elements to the
luminal surface of the graft.
The authors observed by Western blotting increased expres-
sion of endothelial nitric oxide synthase and prostaglandin I syn-
thase in the cyclic shear stress conduits compared with the conduits
created under other conditions. Defining the role of these or other
biologic molecules in conferring favorable graft function will re-
quire formal investigation. The functional performance character-
istics of the endothelial lining of a conduit likely are the result of
many factors, one of which appears to be the type of shear stress
used when creating the endothelial monolayer. Other factors may
include the scaffold, the origin of the endothelial cells and their
culture conditions, both biologic and mechanical.
The ideal conduit for certain applications may also include
smoothmuscle cells along with endothelial cells to allow for amore
durable structure or potentially for biologic molecule delivery via
vascularized structures that have genetically engineered cells de-
signed to deliver physiologic regulatory molecules locally or to the
circulation. Patterns of molecular expression that may be expected
to yield favorable endothelial performance characteristics might
possibly include robust eNOS expression and decreased expression
of tissue factor and other unfavorable candidate molecules.
Additional work, including longer-term studies and studies in
arterial-arterial grafts is required to adequately address the chal-
lenge of adequate conduit design.
